The procedure was a stereoelectroencephalography (SEEG), which uses an intracerebral electrode to measure electrical signals in the brain. The goal of the procedure is to figure out which part of the brain generate the sudden bursts of electrical signals that cause epileptic seizures.
“The robot totally changes how we approach insertion of SEEG electrodes,” said Dr. David Steven, neurosurgeon and co-director of the epilepsy program and London Health Sciences Center. “It is already noticeably faster and more accurate than the previous system. In addition, it allows us to plan trajectories previously impossible with a standard frame, making surgery safer and more accurate.”
Neuromate stereotactic robot provides a consistent, accurate and repeatable platform for therapy and diagnostic procedures. The Neuromate robot enhances the safety and cost-effectiveness of procedures while the neurosurgeon still has direct contact with the patient.
The Neuromate robot has already been installed in many healthcare centers around the world and has been an integral part of more than 10,000 procedures for the last 20 years.
“We are very excited at the opportunity of working together with the distinguished team at London Health Sciences Center. Their advanced research and clinical practice will help up to continue pushing the Neuromate to higher levels. Our team will support Dr. Steven to continue providing the best care for his patients,” said Dr. Abed Hammoud, CEO of Renishaw Mayfield.
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]